[HTML][HTML] Luteolin suppresses gastric cancer progression by reversing epithelial-mesenchymal transition via suppression of the Notch signaling pathway

M Zang, L Hu, Z Fan, H Wang, Z Zhu, S Cao… - Journal of translational …, 2017 - Springer
Background Gastric cancer (GC) is one of the most malignant tumors and the second
leading cause of cancer-related deaths in the world. Luteolin, a flavonoid present in many …

Luteolin suppresses gastric cancer progression by reversing epithelial-mesenchymal transition via suppression of the Notch signaling pathway

L Hu, ZY Fan, HX Wang, ZL Zhu… - Journal of …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Gastric cancer (GC) is one of the most malignant tumors and the second
leading cause of cancer-related deaths in the world. Luteolin, a flavonoid present in many …

Luteolin suppresses gastric cancer progression by reversing epithelial-mesenchymal transition via suppression of the Notch signaling pathway

L Hu, F Zhi-yuan, W He-xiao… - Journal of …, 2017 - search.proquest.com
Background Gastric cancer (GC) is one of the most malignant tumors and the second
leading cause of cancer-related deaths in the world. Luteolin, a flavonoid present in many …

Luteolin suppresses gastric cancer progression by reversing epithelial-mesenchymal transition via suppression of the Notch signaling pathway.

MD Zang, L Hu, ZY Fan, HX Wang, ZL Zhu… - Journal of …, 2017 - europepmc.org
Background Gastric cancer (GC) is one of the most malignant tumors and the second
leading cause of cancer-related deaths in the world. Luteolin, a flavonoid present in many …

[PDF][PDF] Luteolin suppresses gastric cancer progression by reversing epithelial-mesenchymal transition via suppression of the Notch signaling pathway

L Su, C Li, Z Zhu, M Yan, B Liu - 2017 - core.ac.uk
Background: Gastric cancer (GC) is one of the most malignant tumors and the second
leading cause of cancer‑related deaths in the world. Luteolin, a flavonoid present in many …

[HTML][HTML] Luteolin suppresses gastric cancer progression by reversing epithelial-mesenchymal transition via suppression of the Notch signaling pathway

L Hu, Z Fan, H Wang, Z Zhu, S Cao, X Wu… - Journal of …, 2017 - ncbi.nlm.nih.gov
Background Gastric cancer (GC) is one of the most malignant tumors and the second
leading cause of cancer-related deaths in the world. Luteolin, a flavonoid present in many …

Luteolin suppresses gastric cancer progression by reversing epithelial-mesenchymal transition via suppression of the Notch signaling pathway

L Hu, Z Fan, H Wang, Z Zhu, S Cao, X Wu, J Li… - Journal of Translational …, 2017 - infona.pl
Background Gastric cancer (GC) is one of the most malignant tumors and the second
leading cause of cancer-related deaths in the world. Luteolin, a flavonoid present in many …

[HTML][HTML] Luteolin suppresses gastric cancer progression by reversing epithelial-mesenchymal transition via suppression of the Notch signaling pathway

M Zang, L Hu, Z Fan, H Wang… - Journal of …, 2017 - … -medicine.biomedcentral.com
Gastric cancer (GC) is one of the most malignant tumors and the second leading cause of
cancer-related deaths in the world. Luteolin, a flavonoid present in many fruits and green …

[引用][C] Luteolin suppresses gastric cancer progression by reversing epithelial-mesenchymal transition via suppression of the Notch signaling pathway

LH Ming-de Zang, Z Fan, H Wang, Z Zhu… - Journal of Translational …, 2017 - cir.nii.ac.jp
Luteolin suppresses gastric cancer progression by reversing epithelial-mesenchymal transition
via suppression of the Notch signaling pathway | CiNii Research CiNii 国立情報学研究所 学術 …

[PDF][PDF] Luteolin suppresses gastric cancer progression by reversing epithelial-mesenchymal transition via suppression of the Notch signaling pathway

L Su, C Li, Z Zhu, M Yan, B Liu - 2017 - cyberleninka.org
Background: Gastric cancer (GC) is one of the most malignant tumors and the second
leading cause of cancer‑related deaths in the world. Luteolin, a flavonoid present in many …